Secnidazole

(Solosec)

Secnidazole

Drug updated on 11/14/2023

Dosage Formgranules (oral: 2 g/packet)
Drug ClassNitroimidazole antimicrobials
Ongoing and Completed StudiesClinicalTrials.gov

Indication

  • For the treatment of bacterial vaginosis in female patients 12 years of age and older.
  • For the treatment of trichomoniasis in patients 12 years of age and older.

Product Monograph / Prescribing Information

Document TitleYearSource
Solosec (secnidazole) Prescribing Information.2022Lupin Pharmaceuticals Inc., Baltimore, MD

Systematic Reviews / Meta-Analyses